Keyphrases
Morphine
97%
Intracranial Self-stimulation
52%
Knock-in Mouse Model
31%
Antinociception
30%
Ketoprofen
28%
Wild Mice
26%
Uptake Inhibitor
25%
Monoamines
23%
Glutamate Receptor Antagonists
23%
Opioids
22%
Opioid Agonist
22%
Hot Plate
19%
JNJ16259685
15%
N-methyl-D-aspartate Receptor Antagonist
15%
Carboxylic Acids
15%
Lactic Acid
15%
Antinociceptive
15%
Pain Stimulus
14%
CB1 Receptor
13%
Pain Treatment
13%
Abuse Potential
13%
Cannabinoid Signaling
13%
C57BL
12%
Acid Activation
12%
Noxious Stimuli
12%
Persistent Inflammatory Pain
11%
Metabotropic Glutamate
11%
Acute Pain
11%
Dezocine
11%
Opioid Receptors
11%
Hepatocytes
11%
Chronic Unpredictable Stress
11%
Kappa Opioid
11%
Dopamine Release
11%
Receptor Reserve
11%
Discrimination Reversal
11%
Decreasing Effect
11%
Agonist Efficacy
11%
Male Rats
11%
Chlordiazepoxide
11%
Mouse Hepatocytes
11%
Amitifadine
11%
NOX1
11%
Dizocilpine
11%
Conditioned Place Preference
11%
Mesolimbic Dopamine System
11%
CB1 Knockout
11%
Buprenorphine
11%
Chronic Pancreatitis
11%
Murine Cells
11%
Pharmacology, Toxicology and Pharmaceutical Science
Morphine
90%
Mouse
63%
Knockout Mouse
35%
Opiate
30%
Antinociception
28%
Wild Type Mouse
24%
Opiate Agonist
24%
Ketoprofen
23%
Epileptic Absence
15%
Inflammatory Pain
14%
Cannabinoid 1 Receptor
13%
Analgesic Agent
13%
Cannabinoid
13%
Carboxylate
13%
Lactic Acid
13%
C57BL 6 Mouse
12%
Aspartic Acid
11%
Dezocine
11%
Buprenorphine
11%
Glutamate Receptor Antagonist
11%
Cystic Fibrosis
11%
Metabotropic Receptor Antagonist
11%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 1
11%
Pain
11%
Amitifadine
11%
Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor
11%
Drug Vehicle
11%
Chronic Pancreatitis
11%
Ceruletide
11%
Reactive Oxygen Metabolite
11%
Dizocilpine
11%
Chlordiazepoxide
11%
Drug Administration
11%
Phthalic Acid Dioctyl Ester
11%
Morphine-Induced Antinociception
10%
Functional Disease
9%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
8%
NMDA Receptor Antagonist
7%
Intraperitoneal Injection
6%
2 Amino 2 (2 Carboxycyclopropyl) 3 (Xanthen 9 Yl)propionic Acid
5%
Hot Water
5%
Gelatinase B
5%
Western Blot
5%
Capsaicin
5%
URB597
5%
4 (1,1 Dimethylheptyl) 1',2',3',4',5',6' Hexahydro 2,3' Dihydroxy 6' (3 Hydroxypropyl)biphenyl
5%
Endocannabinoid
5%
Neuroscience
Morphine
100%
Behavior (Neuroscience)
53%
Opiate
43%
Ketoprofen
28%
Agonist
23%
Nesting
23%
Monoamine
23%
Epileptic Absence
16%
Lactic Acid
16%
δ -Opioid Receptor
15%
Electrical Brain Stimulation
11%
Cystic Fibrosis
11%
Receptor Reserve
11%
Dopamine Release
11%
Nucleus Accumbens
11%
Aspartic Acid
11%
Chlordiazepoxide
11%
Lateral Hypothalamus
11%
Drug Self-Administration
11%
Dizocilpine
11%
Cannabinoid
11%
Reactive Oxygen Species
11%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 1
11%
Stellate Cell
11%
Medial Forebrain Bundle
11%
Glutamic Acid
11%
Ceruletide
11%
Treatment of Pain
11%
Serotonin Transporter
9%
Dopamine Transporter
9%
NADPH Oxidase
8%
Intraperitoneal Injection
8%
Receptor Agonists
8%
Non-Steroidal Anti-Inflammatory Drug
8%
Norepinephrine Transporter
7%
Eicosanoid Receptor
6%
MMP9
5%
Western Blot
5%